Centinel Spine(R) PMA Application for First-of-its-Kind 2-Level prodisc(R) C Vivo and prodisc C SK Match-the-Disc(TM) Cervical Total Disc Replacement System Filed and Proceeding with Substantive Review
The clinical trial evaluated the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing it with an approved total disc replacement (TDR) product as a control for 2-level indications.
This is the first IDE trial allowing surg... Devices, Neurosurgery, Orthopaedic, FDA Centinel Spine, total disc replacement, prodisc , spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 26, 2023 Category: Pharmaceuticals Source Type: news
Independent Scientific Paper by Doctors Using IceCure's ProSense(R) Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients
Paper cites IceCure's ICE3 interim clinical study results as evidence of safety and efficacy of cryoablation in early-stage breast cancer
CAESAREA, Israel, Oct. 25, 2023 -- (Healthcare Sales & Marketing Network) -- IceCure Medical Ltd. (Nasdaq: ICCM) (... Devices, Oncology IceCure Medical, ProSense System, cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 25, 2023 Category: Pharmaceuticals Source Type: news
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
- Resource consumption will be reduced by 50% to accelerate ALS development
- Plans underway for registrational Phase 3b U.S. clinical trial for NurOwn in ALS
NEW YORK, Oct. 24, 2023 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Thera... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn, stem cell, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2023 Category: Pharmaceuticals Source Type: news
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
First-of-its-kind Aurora EV-ICD system offers single device, single procedure with lead placed outside of heart and veins
DUBLIN, Oct. 23, 2023 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), a global leader in healthcare techno... Devices, Cardiology, FDA Medtronic, Aurora EV-ICD, Extravascular Implantable Cardioverter-Defibrillator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2023 Category: Pharmaceuticals Source Type: news
Groundbreaking New Silk Surgical Dressing, SYLKE(TM), Launches to Prevent Skin Injuries and Infections, Improving Scarring Outcomes
Head-to-head data published in the Aesthetic Surgery Journal Open Forum shows SYLKE wound closure prototype outperforms current standard of care
LA JOLLA, Calif., Oct. 20, 2023 -- (Healthcare Sales & Marketing Network) -- Today, Sylke Inc launched SYL... Devices, Surgery, Wound Care, Product Launch Sylke , silk fibroin, adhesive wound closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 20, 2023 Category: Pharmaceuticals Source Type: news
Antiva Biosciences Strengthens Leadership with Key New Appointments
Company Adds New Chief Medical Officer, Vice President of Project Management & Strategic Initiatives, and Vice President of Technical Operations
REDWOOD CITY, Calif., Oct. 18, 2023 -- (Healthcare Sales & Marketing Network) -- Antiva Biosciences, a biop... Biopharmaceuticals, Personnel Antiva Biosciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2023 Category: Pharmaceuticals Source Type: news
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
Path forward for ALS is a registrational Phase 3b U.S. clinical trial
Biologics License Application to be withdrawn without prejudice
Conference call and webcast at 8:30am ET today
NEW YORK, Oct. 18, 2023 -- (Healthcare Sales & Marketing Network) ... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2023 Category: Pharmaceuticals Source Type: news
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
MIAMI LAKES, Fla., Oct. 16, 2023 -- (Healthcare Sales & Marketing Network) -- Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technology, strongly supports the decision made by the Centers ... Devices, Interventional, Reimbursement Cordis , carotid artery stenting, carotid stent, PRECISE PRO RX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2023 Category: Pharmaceuticals Source Type: news
Prominent U.S. hospital expands RayStation installation for proton treatment planning
STOCKHOLM, Oct. 13, 2023 -- (Healthcare Sales & Marketing Network) -- RaySearch Laboratories AB (publ) announces that the Mass General Cancer Center plans to expand its use of RayStation®* to proton treatment planning.
RayStation is a flexible, inn... Devices, Oncology RaySearch Laboratories, RayCare, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2023 Category: Pharmaceuticals Source Type: news
Centinel Spine Surgical Stadium Event at NASS 2023 to Demonstrate Value of prodisc(R) Match-the-Disc(TM) Cervical and Lumbar Total Disc Replacement Systems
Centinel Spine is the only company to offer cervical and lumbar total disc replacement (TDR) systems that allow matching the disc to the needs of the patient and surgeon.
Centinel Spine recently announced that more than 250,000 prodisc devices have been... Devices, Orthopaedic, Neurosurgery Centinel Spine, prodisc , total disc replacement, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2023 Category: Pharmaceuticals Source Type: news
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment
Labcorp is the first company to deliver a blood-based Amyloid-Tau-Neurodegeneration (ATN) Profile, which ... Diagnostics, Neurology, Product Launch Labcorp , ATN Profile, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 11, 2023 Category: Pharmaceuticals Source Type: news
Body Vision Medical Announces Successful Validation of LungVision(TM) System with Ziehm Imaging's Mobile C-Arms
CAMPBELL, Calif., Oct. 10, 2023 -- (Healthcare Sales & Marketing Network) -- Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced today the successful validation of Body Vision's LungVision system with the entire product line of ... Devices, Radiology Body Vision Medical, LungVision system, Ziehm Imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 10, 2023 Category: Pharmaceuticals Source Type: news
Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
The PROACTIVE-HF 2 trial is designed to expand access to NYHA class II patients and to scale pulmonary artery pressure-guided therapy with the Cordella Sensor
In addition, the Company presented positive 12-month clinical data on a subset of patients in ... Devices, Interventional, Cardiology, FDA Endotronix, Cordella Sensor, pulmonary artery, pressure-guided therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 9, 2023 Category: Pharmaceuticals Source Type: news
Amgen Completes Acquisition of Horizon Therapeutics plc
Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines
THOUSAND OAKS, Calif., Oct. 6, 2023 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition of Horizon... Biopharmaceuticals, Mergers & Acquisitions Amgen, Horizon Therapeutics, TEPEZZA, KRYSTEXXA, UPLIZNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2023 Category: Pharmaceuticals Source Type: news
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Mitokinin's lead compound, a selective PINK1 activator, is designed to address mitochondrial dysfunction, which plays a key role in the pathogenesis of Parkinson's disease
Activation of PINK1 remediates mitochondrial damage and restores mitochondrial fu... Biopharmaceuticals, Neurology, Mergers & Acquisitions AbbVie, Mitokinin, Parkinson's Disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 5, 2023 Category: Pharmaceuticals Source Type: news
